finance wales investing in life sciences. who are we? the finance wales group comprises: finance...

15
Finance Wales Investing in life sciences

Upload: chastity-bennett

Post on 11-Jan-2016

217 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Finance Wales Investing in life sciences. Who are we?  The Finance Wales Group comprises:  Finance Wales  FW Capital, our non Welsh fund management

Finance WalesInvesting in life sciences

Page 2: Finance Wales Investing in life sciences. Who are we?  The Finance Wales Group comprises:  Finance Wales  FW Capital, our non Welsh fund management

Who are we? The Finance Wales Group comprises: Finance Wales FW Capital, our non Welsh fund management business xénos, our business angel network Commercially independent company providing

investment funding to SMEs in Wales Invests private/public funds

Page 3: Finance Wales Investing in life sciences. Who are we?  The Finance Wales Group comprises:  Finance Wales  FW Capital, our non Welsh fund management

Our investments (£’m)

Page 4: Finance Wales Investing in life sciences. Who are we?  The Finance Wales Group comprises:  Finance Wales  FW Capital, our non Welsh fund management

Finance Wales funds Funds we are currently investing:

Wales JEREMIE Fund - £150m Wales SME Investment Fund - £40m Wales Technology Seed Fund - £7.5m Wales Micro-business Loan Fund - £6m Wales Property Development Fund - £10m Wales Capital Growth Fund - £20m

Consistently invests over £30m per annum in Welsh companies

Total funds under management in excess of £400m

Page 5: Finance Wales Investing in life sciences. Who are we?  The Finance Wales Group comprises:  Finance Wales  FW Capital, our non Welsh fund management

Finance Wales Venture Capital Funds

What are looking for?Entrepreneurial teams seeking to transform big ideas into game-changing companies.

Page 6: Finance Wales Investing in life sciences. Who are we?  The Finance Wales Group comprises:  Finance Wales  FW Capital, our non Welsh fund management

Seed Fund details:

• £5m over five year investment period• Investment of £50k - £150k• Operated under De Minimis (must be cumulated)• Structure:

• Convertible Loan notes with conversion discount• Straight equity if existing or new co-investors participating

• Focused on technology based businesses• Start ups, University and NHS Spinouts, Large co spin offs• Pan Wales coverage

Page 7: Finance Wales Investing in life sciences. Who are we?  The Finance Wales Group comprises:  Finance Wales  FW Capital, our non Welsh fund management

Venture Fund details:

• Investment of £150k - £1m+• Structure:

• Determined by requirements of opportunity• Can invest along or alongside coinvestors

• Technology focus• High growth potential IP-based companies

• Pan Wales coverage

Page 8: Finance Wales Investing in life sciences. Who are we?  The Finance Wales Group comprises:  Finance Wales  FW Capital, our non Welsh fund management

Our co-investors

20 Co-investors 63 investment rounds £31.7m co-investment

Page 9: Finance Wales Investing in life sciences. Who are we?  The Finance Wales Group comprises:  Finance Wales  FW Capital, our non Welsh fund management

Desirable attributes:

• A compelling idea that reflects a deep understanding of a big problem or opportunity, and offers an elegant solution. And………

• A strong core team, not a world-class, all-gaps-filled team. But the founders have to have the credibility to launch the company and attract future talent that is needed to fill the gaps. Winning over investors depends on your people skills, not just your technical prowess.

Page 10: Finance Wales Investing in life sciences. Who are we?  The Finance Wales Group comprises:  Finance Wales  FW Capital, our non Welsh fund management

Desirable attributes:

• Market opportunity - you should be targeting a technology sector that is not already crowded, where there is a significant problem that needs to be solved, or an opportunity that has not been exploited, and where your solution will create substantial value.

• Technology with a robust and sustainable advantage (and IP?) which attracts plenty of customers with plenty of money that desperately need it or want it.

Page 11: Finance Wales Investing in life sciences. Who are we?  The Finance Wales Group comprises:  Finance Wales  FW Capital, our non Welsh fund management

Desirable attributes:

• Competitive advantage – Your product/service must have advantages that address all forms of competition, and that can sustain these advantages over several years.

• Financial projections – well articulated projections demonstrate that you understand the economics of your business. They should explain what drives your growth, what drives your profit, and how your company will evolve over the next several years.

Page 12: Finance Wales Investing in life sciences. Who are we?  The Finance Wales Group comprises:  Finance Wales  FW Capital, our non Welsh fund management

Desirable attributes:

• Validation – key questions:• Is there good evidence that your solution will be purchased

by your target customers? • Do you have an advisory board of credible industry experts?• Do you have a co-development partner within the industry?• Do you have beta customers to whom investors can speak?• Do you already have paying customers? • What other brand name validators can you offer?

The more credibility and customer traction you have, the more likely investors are going to be interested.

Page 13: Finance Wales Investing in life sciences. Who are we?  The Finance Wales Group comprises:  Finance Wales  FW Capital, our non Welsh fund management

• Cardiff University spinout with R & D support from Welsh Government

Follow on round of £75k to develop new applications

Series B round of £300k to drive US sales

- Ultrasound training simulators

Co-investment of £725k withFusion and IP Group

Page 14: Finance Wales Investing in life sciences. Who are we?  The Finance Wales Group comprises:  Finance Wales  FW Capital, our non Welsh fund management

Academic research project > International business (10yrs) FW first investment in 2009 – systems development 2013 sales – £1.6m. 2014 forecast sales £3.2m Established US office and global distribution partners Leveraged c. £2.5m of private investment Employs 16 staff, WG – HPS, Smart grant, R & D tax credits Recruited US based chairman 2nd generation systems and software 100 systems across 12 Countries Exit 2-3 years? Early OEM interest

Page 15: Finance Wales Investing in life sciences. Who are we?  The Finance Wales Group comprises:  Finance Wales  FW Capital, our non Welsh fund management

Thank you

Any questions…?

Dr Melanie Goward

[email protected] 2033 8112